Advertisement
Screener

Frontline plc (FRO) Spending and interest coverage

Frontline plc (FRO) Spending and interest coverage

  • R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2022-06-30..
  • Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2022-06-30..
  • Interest coverage · 12 months: Value 1.25×; Formula and calculation Operating income ÷ reported interest expense..

Spending and interest coverage

Overview →

Financial period ending 2022-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months(m)Research and development expense / revenue. Period ending 2022-06-30.

Calculation unavailable: missing inputs remain (m).

Stock-based compensation / revenue · 12 months(m)Share-based compensation / revenue. Period ending 2022-06-30.

Calculation unavailable: missing inputs remain (m).

Interest coverage · 12 months1.25×Operating income ÷ reported interest expense.

$85.03M ÷ $67.92M ≈ 1.25×

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending(m)
Revenue726.31M USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation(m)
Operating income85.03M USDOperating Income (Loss)
Interest expense · reported / estimated67.92M USDInterest Expense · Estimated expense assumptions

Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2022-06-30(m)$726.31M(m)$85.03M$67.92M(m)(m)1.25×Reported
2021-12-31(m)$640.33M(m)$12.22M$61.44M(m)(m)0.20×Reported
2021-06-30(m)$518.87M(m)$86.83M$60.72M(m)(m)1.43×Reported
2020-12-31(m)$428.43M(m)$507.80M$72.16M(m)(m)7.04×Reported
2020-06-30(m)$507.77M(m)$577.74M$88.64M(m)(m)6.52×Reported
2019-12-31(m)$628.48M(m)$239.52M$94.46M(m)(m)2.54×Reported
2019-06-30(m)$734.56M(m)$176.71M$94.25M(m)(m)1.87×Reported
2018-12-31(m)$742.27M(m)$82.71M$93.28M(m)(m)0.89×Reported
2018-06-30(m)$655.49M(m)$-233.89M$84.53M(m)(m)-2.77×Reported
2017-12-31(m)$646.33M(m)$-196.27M$69.81M(m)(m)-2.81×Reported
2017-06-30(m)$662.72M(m)$77.05M$59.91M(m)(m)1.29×Reported
2016-12-31(m)$754.31M(m)$177.48M$56.69M(m)(m)3.13×Reported
2016-06-30(m)$680.34M(m)$285.32M$39.37M(m)(m)7.25×Reported
2015-12-31(m)$458.93M(m)$287.22M$17.62M(m)(m)16.30×Reported
2015-06-30(m)$549.87M(m)$83.86M$59.93M(m)(m)1.40×Reported
2014-12-31(m)$559.69M(m)$-48.60M$75.83M(m)(m)-0.64×Reported
2014-06-30(m)$559.03M(m)$-60.22M$87.97M(m)(m)-0.68×Reported
2013-12-31(m)$517.19M(m)$-100.43M$90.72M(m)(m)-1.11×Reported
2013-09-30(m)$616.15M(m)$-125.94M$92.20M(m)(m)-1.37×Reported
2013-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-03-31(m)$644.76M(m)$-10.48M$93.56M(m)(m)-0.11×Reported
2012-12-31(m)$668.11M(m)$7.24M$94.96M(m)(m)0.08×Reported
2012-09-30(m)$652.65M(m)$-304.99M$109.00M(m)(m)-2.80×Reported
2012-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2011-12-31(m)$810.10M(m)$-399.60M$141.50M(m)(m)-2.82×Reported
2011-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2010-12-31(m)$1.17B(m)$307.91M$149.92M(m)(m)2.05×Reported
2009-12-31(m)$1.13B(m)$240.11M$160.99M(m)(m)1.49×Reported
2008-12-31(m)$2.10B(m)$850.48M$183.93M(m)(m)4.62×Reported

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.